Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preclinical evaluation of a multi-epitope mRNA vaccine platform for broad and durable SARS-CoV-2 protection.

Frontiers in immunology·2026
Same author

Homologous MVA and heterologous DREP/MVA vaccine regimens induce robust and durable immune responses against SARS-CoV-2.

Scientific reports·2026
Same author

Diagnosis of HIV infection during pregnancy: Trends from a national cohort in Spain.

HIV medicine·2025
Same author

Immunogenicity and efficacy of homologous and heterologous NDV and MVA SARS-CoV-2 vaccines in mice and hamsters.

NPJ vaccines·2025
Same author

Structural basis of poxvirus fusion regulation and anti-A16/G9 antibody-mediated neutralization and protection.

Cell·2025
Same author

ISG15 as a Potent Immune Adjuvant in MVA-Based Vaccines Against Zika Virus and SARS-CoV-2.

Vaccines·2025

Related Experiment Video

Updated: Apr 20, 2026

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors
09:16

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors

Published on: October 30, 2016

12.0K

Enhancing poxvirus vectors vaccine immunogenicity.

Juan García-Arriaza1, Mariano Esteban

  • 1a Department of Molecular and Cellular Biology; Centro Nacional de Biotecnología; Consejo Superior de Investigaciones Científicas (CSIC); Madrid, Spain.

Human Vaccines & Immunotherapeutics
|November 27, 2014
PubMed
Summary

Improving attenuated recombinant poxvirus vectors is crucial for enhancing vaccine efficacy. Strategies focus on boosting immunogenicity and protective immune responses against pathogens.

Keywords:
immunogenicitypoxvirusrecombinantsvaccinesvector improvements

More Related Videos

Rapid, Seamless Generation of Recombinant Poxviruses using Host Range and Visual Selection
09:25

Rapid, Seamless Generation of Recombinant Poxviruses using Host Range and Visual Selection

Published on: May 24, 2020

5.9K
Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

10.9K

Related Experiment Videos

Last Updated: Apr 20, 2026

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors
09:16

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors

Published on: October 30, 2016

12.0K
Rapid, Seamless Generation of Recombinant Poxviruses using Host Range and Visual Selection
09:25

Rapid, Seamless Generation of Recombinant Poxviruses using Host Range and Visual Selection

Published on: May 24, 2020

5.9K
Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

10.9K

Area of Science:

  • Virology
  • Immunology
  • Vaccinology

Background:

  • Attenuated recombinant poxvirus vectors show promise in clinical trials due to safety and immunogenicity.
  • Limitations in efficacy and replication capacity of current vectors (e.g., ALVAC, MVA, NYVAC) necessitate further improvements.

Purpose of the Study:

  • To review current and novel strategies for enhancing the immunogenicity of poxvirus vectors.
  • To identify approaches for optimizing protective immune responses and long-lasting immunity.

Main Methods:

  • Review of existing literature on poxvirus vector development.
  • Analysis of strategies including heterologous prime/boost, co-stimulatory molecules, gene deletion, promoter enhancement, and adjuvant use.

Main Results:

  • Multiple strategies are being explored to overcome limitations of current poxvirus vectors.
  • Combined approaches may yield optimized vectors with improved efficacy.

Conclusions:

  • Further optimization of poxvirus vectors is essential for developing effective vaccines.
  • Future research should focus on strategies that induce robust, long-lasting protective immunity.